Clinical Trial Update: LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB) [NA]

View source ↗

Summary

A completed continuation registry study for the Lutonix drug-coated balloon in peripheral artery disease; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Lutonix (paclitaxel-coated balloon catheter)

Snippet

Sponsor: C. R. Bard | Conditions: Peripheral Artery Disease | NA | Status: COMPLETED | Results posted: 2020-04-10